Skip to main content

Table 2 Cardiometabolic risk factor clusters by total number and specific classes of antihypertensive medication in drug regimen

From: Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States

Number of Cardiometabolic Risk Factors

Cardiometabolic Risk Factor Cluster

ACE or ARB (%)

Any Diuretic (%)

CCB (%)

BB (%)

Total # (%) of Patients

# of antihypertensive meds (mean, SD)

0

-O -DM -HL

57.6%

42.7%

25.9%

31.1%

1197 (18.3%)

1.7 (1.1)

1

-O -DM +HL

60.3%

42.3%

29.1%

36.7%

1537 (23.5%)

1.8 (1.0)

 

+O -DM -HL

60.5%

50.6%

28.5%

31.8%

959 (14.7%)

1.9 (1.1)

 

-O +DM -HL

67.1%

45.7%

27.2%

38.7%

173 (2.7%)

2.0 (1.1)

2

+O -DM +HL

65.1%

53.3%

26.7%

39.8%

1178 (18.0%)

2.0 (1.1)

 

-O +DM +HL

78.7%

43.8%

29.5%

42.6%

441 (6.8%)

2.1 (1.2)

 

+O +DM -HL

73.5%

52.2%

32.7%

36.3%

245 (3.8%)

2.2 (1.3)

3

+O +DM +HL

82.1%

58.2%

32.1%

42.0%

797 (12.2%)

2.4 (1.2)

Total (n = 6,527)

 

65.3%

48.1%

28.5%

36.6%

6527 (100.0%)

2.0 (1.1)

  1. O = obese (BMI ≥ 30); DM = diabetes; HL = dyslipidemia.
  2. Row percentages by medication class do not total to100% since patients may be using more than one antihypertensive medication class.